Clinical Trial Update: Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating secukinumab versus placebo on aortic vascular inflammation in moderate to severe plaque psoriasis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2019-07-09